BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 11417181)

  • 21. Ambroxol plus amoxicillin in the treatment of exacerbations of chronic bronchitis.
    Peralta J; Poderoso JJ; Corazza C; Fernández M; Guerreiro RB; Wiemeyer JC
    Arzneimittelforschung; 1987 Aug; 37(8):969-71. PubMed ID: 3675696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Experience in treating patients with chronic obstructive bronchitis with fenspirid].
    Kirichenko AA; Shabanova TM
    Ter Arkh; 2002; 74(8):52-5. PubMed ID: 12360597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraluminal inflammation in the airways of patients with chronic bronchitis after treatment with Ambroxol.
    Lusuardi M; Capelli A; Salmona M; Tacconi MT; Cerutti CG; Donner CF
    Monaldi Arch Chest Dis; 1995 Oct; 50(5):346-51. PubMed ID: 8541815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of lasolvan on mucociliary transport in patients with chronic nonspecific lung diseases].
    Solopov VN; Kolganova NA
    Klin Med (Mosk); 1988 Mar; 66(3):45-7. PubMed ID: 3392922
    [No Abstract]   [Full Text] [Related]  

  • 25. [Secretolytic effect of sobrelol and improvement of pulmonary ventilation in patients with chronic pulmonary tuberculosis associated with chronic bronchitis].
    Bosisio E; Sergi M; Nunziante A; Baudin E
    G Ital Mal Torace; 1971; 25(3):145-61. PubMed ID: 5143403
    [No Abstract]   [Full Text] [Related]  

  • 26. [Mucolytic bisolven (further experiences in the treatment of chronic bronchitis and bronchial asthma)].
    Beritić T
    Lijec Vjesn; 1970; 91(11):1200-2. PubMed ID: 5200810
    [No Abstract]   [Full Text] [Related]  

  • 27. Antiinflammatory properties of ambroxol.
    Beeh KM; Beier J; Esperester A; Paul LD
    Eur J Med Res; 2008 Dec; 13(12):557-62. PubMed ID: 19073395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Results of a clinical trial with ambroxol as to postoperative therapy of bronchitis (author's transl)].
    Kranicke R
    Arzneimittelforschung; 1978; 28(5a):934-5. PubMed ID: 581994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative studies on the mucolytic effectiveness of Mucosolvin oral and Mucosolvin inhalant].
    Fischer JF; Scheuler D
    Z Erkr Atmungsorgane; 1986; 167(1-2):96-102. PubMed ID: 3765720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of decamethoxine in the complex treatment of chronic bronchitis].
    Iukhimets VA; Pilipchuk VN
    Klin Med (Mosk); 1990 Feb; 68(2):91-4. PubMed ID: 2335954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of ketotifen on the eicosanoid system, immunoreactivity and bronchial patency in patients with obstructive pulmonary diseases].
    Efimov VV; Blazhko VI; Liashenko MM; Voeĭkova LS; Bondar' TN
    Ter Arkh; 1991; 63(3):70-3. PubMed ID: 1648274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rheological modifications of mucus in chronic bronchitic patients after treatment with stepronine-lysine salt.
    Braga PC; Bossi R; Allegra L
    Drugs Exp Clin Res; 1987; 13(11):707-10. PubMed ID: 3443046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapeutic study on ambroxol in chronic bronchopulmonary diseases (author's transl)].
    Curti PC; Renovanz HD
    Arzneimittelforschung; 1978; 28(5a):922-5. PubMed ID: 581991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [On the treatment of some forms of acute and chronic bronchial diseases with N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride].
    Trombini V
    Minerva Med; 1969 Sep; 60(76):3600-3. PubMed ID: 5823757
    [No Abstract]   [Full Text] [Related]  

  • 35. [Lysozyme level and rheological properties of the sputum in patients with chronic bronchitis].
    Solopov VN; Kolganova NA; Reznikov II; Plisko LF; Dvoretskiĭ LI
    Ter Arkh; 1986; 58(4):57-9. PubMed ID: 3715759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Normalization of bronchial exocrine pathology after endobronchial treatment with ambroxol.
    Aliperta A; Bellissimo U; Turco D; Antinolfi G
    Int J Tissue React; 1986; 8(2):167-74. PubMed ID: 2939036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients.
    Basyigit I; Yildiz F; Ozkara SK; Boyaci H; Ilgazli A
    Mediators Inflamm; 2004 Aug; 13(4):285-91. PubMed ID: 15545060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pediatric Asthma-Bisolvon suppositories in the treatment of asthmatic bronchitis and bronchial asthma in childhood].
    Kessler H
    Fortschr Med; 1972 Sep; 90(27):993-5. PubMed ID: 4653175
    [No Abstract]   [Full Text] [Related]  

  • 39. [Temporal organization of external respiratory function in elderly patients with chronic obstructive lung disease].
    Zaslavskaia RM; Veklenko GV; Teĭblium MM
    Klin Med (Mosk); 2004; 82(7):36-40. PubMed ID: 15449772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of bronchial asthma and bronchitis with mucolytic drugs].
    Chalon Z; Gruszecki J; Hadydoń B
    Pol Tyg Lek; 1966 Jul; 21(27):1040-2. PubMed ID: 5925941
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.